82 filings
Page 4 of 5
8-K
bdqo8lcuacg69s3iu0z
27 Feb 20
Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results
4:11pm
8-K
bodjci6r0jm3
13 Jan 20
Regulation FD Disclosure
8:02am
8-K
lekx1c
18 Dec 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
lraaf9ckz1 8m4
14 Nov 19
Tricida Announces Third Quarter 2019 Financial Results
4:34pm
8-K
slrrdrcup
15 Oct 19
Regulation FD Disclosure
8:03am
8-K
1g4620
10 Oct 19
Entry into a Material Definitive Agreement
4:25pm
8-K
5w9j1498 um7
4 Sep 19
Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
9:27am
8-K
1vyaot7fgxlq5rtcv
19 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
lall5yb 6n7g8sj1q
8 Aug 19
Tricida Announces Second Quarter 2019 Financial Results
4:08pm
8-K
tkk1 yzlb2amno1c1
25 Jun 19
Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet
8:35am
8-K
mog9loppj6fmyb8rdq0u
31 May 19
Submission of Matters to a Vote of Security Holders
4:39pm
8-K
qtg2bck
8 May 19
Tricida Announces First Quarter 2019 Financial Results
4:08pm
8-K
yezdwx19 z9fz0p
28 Mar 19
Tricida Announces Positive Results from Long-Term Clinical Trial
7:29am
8-K
yqyutvle
28 Mar 19
Entry into a Material Definitive Agreement
7:27am
8-K
1ipkpo 2p
28 Mar 19
Tricida Announces Fourth Quarter and Full-Year 2018 Financial Results
7:25am
8-K
dqaq4
22 Feb 19
Departure of Directors or Certain Officers
12:00am
8-K
dbtdux
7 Jan 19
Regulation FD Disclosure
8:52am
8-K
uouhv lms
3 Jan 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
ux1h9 hnjg2
8 Nov 18
Tricida Announces Third Quarter 2018 Financial Results
4:27pm
8-K
r9b1fx
18 Oct 18
Entry into a Material Definitive Agreement
4:26pm